DPC Report Card on Medigap Coverage for
ESRD Patients Under 65 Years of Age
61% of ESRD patients are under 65 years old, but only 11% currently have Medigap coverage.
We must do better!
Medigap provides dialysis patients with financial security and access to lifesaving transplant surgery. Medicare only pays for 80% of an individual’s health care costs, making access to Medigap coverage critical for helping dialysis patients cover the remaining 20%. We need your support to help ensure all dialysis patients gain access to Medigap coverage regardless of age. Contact your Members of Congress today.
- All States
- Grade: A (8)
- Grade: B (7)
- Grade: C (16)
- Grade: D (17)
- Grade: F (3)
DPC Grades Based on Patient Access & Affordability:
A State requires all/most plans to be offered and affordable to ESRD patients under 65.B State requires some plans to be offered and affordable to ESRD patients under 65. C State requires some plans to be offered, but they are not affordable to most ESRD patients under 65. D State does not require coverage. Some plans are offered, but they are not affordable to most ESRD patients under 65. F State excludes coverage. Some plans may be offered, but they are not affordable to most ESRD patients under 65.
While Original Medicare covers 80% of medical costs for eligible beneficiaries, those without any type of supplemental insurance policy – such as Medigap or employer-sponsored secondary insurance – individuals must pay the remaining 20% co-insurance, co-pays and deductibles on their own. Since original Medicare has no annual cap for the 20% out-of-pocket co-insurance expenses, this can cause serious financial strain for many Medicare beneficiaries. Some End Stage Renal Disease (ESRD) patients under age 65 who lack access to supplemental insurance are forced to spend down their assets to become eligible for Medicaid coverage. This is financially devastating for these individuals and, in the end, will cost the State – and its taxpayers – more money.
Medigap is a supplemental insurance policy option specifically for Medicare beneficiaries designed to fill the “gaps” in Original Medicare coverage to provide greater financial stability and security for patients. Patients with access to Medigap select an available plan option offered by commercial insurers and pay a fixed monthly premium amount that helps cover and cap their out-of-pocket co-pays and deductibles that Medicare alone doesn’t cover. The problem, however, is that Medigap coverage isn’t currently accessible to all ESRD patients who are on Medicare.
When Medigap plans were first introduced, Congress only guaranteed issue of these plans to traditional Medicare beneficiaries (those age 65 and older who are enrolled in Medicare Parts A and B) without consumer protections and did not extend this protection to disability and ESRD patients who obtain Medicare coverage prior to age 65. Without a federal mandate to extend coverage to all Medicare-eligible beneficiaries regardless of age, states are left to determine their own Medigap policy for disability and ESRD patients under age 65. People on dialysis face serious financial struggles and difficulty accessing kidney transplantation in areas where Medigap coverage is not accessible. That’s why DPC continues to advocate for every person on dialysis to be able to purchase affordable and nondiscriminatory Medigap coverage regardless of age.
Health policy experts often criticize Medigap’s relief from cost sharing as adding to Medicare expenditures. However, using Medicare cost data from 2017-2019, HMA estimated that extending Medigap coverage to all ESRD patients under the age of 65 would only add about $50 million in federal expenditures over the next 10 years. HMA actuaries compared the utilization of services by dual eligible dialysis patients vs. Medicare-only dialysis beneficiaries, and found that the one relevant increase in cost was in drug spend. HMA suspects that by expanding access to Medigap coverage, more dialysis patients will have the money to pay for all of their prescribed medications, as their supplemental insurance would now cover their other health care related expenses. Therefore, HMA projected a de minimis cost increase to Medicare due to increased utilization under Part D following the expansion of Medigap access to patients under 65 years of age. At the same time, the potential increase in medication adherence could lead to better health outcomes and reduced complications.
National Kidney Month Reminds Us of the Possibilities of Life on Dialysis
The coming March marks the start of National Kidney Month, a time to promote kidney health, raise awareness of the obstacles facing patients, and advocate for policies that help them as they navigate life with [...]
2023 State Advocacy Kick-Off
It’s been a busy start in 2023 for DPC’s state advocacy efforts. Bills impacting dialysis patients are being introduced in multiple state legislatures and moving quickly through the legislative process. Legislation to expand Medigap access [...]
The 118th Congress was sworn in earlier this month. It started off in historic fashion with a protracted fight on the House floor to elect a Speaker of the House, which Kevin McCarthy ultimately achieved [...]
DPC Engaging State Policy Makers During Summer Months
While most state legislatures are adjourned during the summer months, DPC’s state advocacy program, under the leadership of Eastern Advocacy Director Elizabeth Lively, is focused on keeping the dialog moving with state legislative policy makers. [...]
Rhode Island Medigap Legislation Signed by Governor McKee
On June 30,2022, Rhode Island Governor Dan McKee signed into law H. 7244 and S. 2194, which provide guaranteed issue access to Medicare Supplement Insurance coverage – known as Medigap – for under age 65 [...]
Rhode Island Passes Medigap Access Legislation
On Thursday, June 23, 2022, the Rhode Island General Assembly held the final vote leading to passage of two bills granting access to Medigap coverage for dialysis patients under age 65. Sponsored by Rep. Brian [...]